The Influence of Hyperglycemia on Outcome of Cerebral Infarction

Abstract

Objective: To determine whether hyperglycemia in the acute stroke period is associated with worse survival and functional outcome after accounting for acute stress response and chronic hyperglycemia.

Design: Prospective, county-wide, multicenter cohort study.

Setting: A community hospital, a university hospital, and a Veterans Affairs hospital.

Patients: A cohort of 146 patients hospitalized with new atherothrombotic stroke.

Measurements: Admission blood glucose concentration, demographic characteristics of patients, 24-hour urinary catecholamine, serum cortisol, and glycosylated hemoglobin levels; outcomes included mortality and functional outcome (Barthel index and Fugl-Meyer score) at 5, 30, 90, and 180 days after stroke.

Results: Of the 996 patients with possible acute stroke who were screened, 146 (15%) were eligible for and consented to participate in the study; in most cases, exclusion from study was based on the absence of acute, atherothrombotic stroke. Overall, no evidence was found of a significant univariate association between admission blood glucose level and survival (relative risk, 1.02; 95% Cl, 0.94 to 1.09) or functional outcome (univariate regression coefficient for adjusted Fugl-Meyer score at day 30, - 0.36; Cl, - 1.08 to 0.27). This absence of an association persisted after adjustment for significant predictors of outcome in a multivariate model.

Conclusions: These data do not support an association between level of glycemia and outcome from acute stroke.

Article and Author Information

  • From Duke University and the Durham Veterans Affairs Medical Center, Durham, North Carolina. For current author addresses, see end of text.

  • Grant Support: In part by grant NS 06233 from the National Institute for Neurological Diseases and Stroke.

  • Requests for Reprints: David B. Matchar, MD, Center for Health Policy Research and Education, Suite 125, Old Chemistry Building, Duke University, Durham, NC 27706.

  • Current Author Addresses: Dr. Matchar: Center for Health Policy Research and Education, Suite 125, Old Chemistry Building, Duke University, Durham, NC 27706.

    Dr. Divine: Henry Ford Health System, Division of Biostatistics, Research Epidemiology and Computing, 23725 Northwestern, Southfield, MI 48075.

    Dr. Heyman: Division of Neurology, Department of Medicine, Box 3240, Duke University Medical Center, Durham, NC 27710.

    Dr. Feussner: Division of General Internal Medicine, Department of Medicine, Box 3240, Duke University Medical Center, Durham, NC 27710.

| Table of Contents
Most Read Most Read
Most Commented Most Commented On
Annals in the News Annals in the News
Clinical Trials Clinical Trials
Comparative Effectiveness Comparative Effectiveness
Hospital Medicine Hospital Medicine
  • Advertisement
  • Advertisement